Loading...
Advicenne S.A.
ALDVI.PA•EURONEXT
Healthcare
Biotechnology
€1.76
€0.01(0.57%)
Advicenne S.A. (ALDVI.PA) Stock Overview
Explore Advicenne S.A.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for ALDVI.PAStats details for ALDVI.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ALDVI.PAAnalyst Recommendations details for ALDVI.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Advicenne S.A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria. Advicenne S.A. was founded in 2007 and is headquartered in Paris, France.
CEO
Mr. Didier Laurens
Employees
21
Headquarters
3ème étage 262, Paris
Founded
2017